CME vs NDAQ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 24, 2026

CME

60.3
AI Score
VS
CME Wins

NDAQ

60.0
AI Score

Investment Advisor Scores

CME

60score
Recommendation
BUY

NDAQ

60score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CME NDAQ Winner
Forward P/E 23.8663 25.9067 CME
PEG Ratio 5.2561 1.9049 NDAQ
Revenue Growth -3.0% 2.9% NDAQ
Earnings Growth -0.4% 37.7% NDAQ
Tradestie Score 60.3/100 60.0/100 CME
Profit Margin 59.0% 19.9% CME
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.